Ozempic, GPL-1s May Help Curb Substance Use Disorders, Study Finds

UTEP study finds GLP-1 drugs may curb substance abuse

EL PASO, Texas (KTSM) -- A new study by researchers at the University of Texas at El Paso found that using weight loss drugs like Ozempic and other GLP-1s may help curb alcohol, opioid, nicotine and cocaine use disorders. UTEP School of Pharmacy researchers Tadesse Abegaz, Ph.D., and Gabriel Frietze, Ph.D., led the study, which [...]

Ozempic, GPL-1s may help curb substance use disorders, study finds

A new study led by researchers at the University of Texas at El Paso found that use of weight-loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.

Weight loss drugs linked to lower risk of alcohol, opioid, nicotine and cocaine use disorders

A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.

GLP-1 Drugs Linked to Lower Rates of Substance Use Disorders

A study led by researchers at the University of Texas at El Paso (UTEP) has found that people with type 2 diabetes or obesity who were prescribed GLP-1 receptor agonists (GLP-1 RAs) had substantially lower odds of developing alcohol, opioid, nicotine, and cocaine use disorders compared with similar individuals who were not taking the medications. The research, published in the journal Frontiers in Psychiatry, used health data from more than 142,…